How Analysts Value SpaceX at $12 Trillion and Why Price Targets Signal Sentiment

The artificial intelligence boom has pushed Wall Street into a new frontier of valuation, and Space Exploration Technologies Corp. is the current epicenter. Following SpaceX’s record-breaking initial public offering in June 2026, investment banks have initiated coverage with price targets that stretch the boundaries of traditional financial modeling. Citigroup recently projected that the company’s market capitalization could eventually reach $12 trillion, setting a near-term target of $200 per share as a milestone along the path to $900.[1]

Other major institutions have followed suit with similarly astronomical figures. Raymond James issued a price target of $800 per share—nearly 500% above the company’s $135 IPO price—while Deutsche Bank labeled the firm the "apex of civilizational ambition" with a $255 target. For retail investors watching the stock trade near $141.50, giving it a $1.9 trillion valuation, these targets can look like a flashing green light to buy.[1]

However, the sheer scale of these projections raises fundamental questions about how investment banks arrive at their numbers. When a major financial institution publishes a 12-month price target, it reads like a precise, probabilistic forecast of where the stock will trade. But peeling back the mechanics of sell-side research reveals a process driven as much by institutional incentives and highly sensitive assumptions as by objective financial reality.[6]

At the core of almost every Wall Street price target is a Discounted Cash Flow (DCF) model. This valuation method requires an analyst to project a company’s future revenue and free cash flow out over a specific time horizon, and then discount those future earnings back to their present value. The goal is to determine what the business is intrinsically worth today based on its ability to generate cash tomorrow.[3]

To build these models, analysts pull historical financial data from public databases like the SEC's EDGAR system and extrapolate growth rates. For a mature, dividend-paying company, this process is relatively straightforward. But for a hyper-growth firm like SpaceX, the models require projecting revenues decades into the future. Raymond James, for instance, based its $800 target on the assumption that SpaceX will generate $5.2 trillion in annual revenue and $2.63 trillion in free cash flow by the year 2035.[1][5]

The vulnerability of the DCF model lies in its extreme sensitivity to these long-term assumptions. A minor adjustment to the projected growth rate or the discount rate can alter the final price target by hundreds of percentage points. This mathematical elasticity allows analysts to justify almost any valuation by tweaking the inputs, making the final target highly dependent on the analyst's underlying optimism.[3][6]

This dynamic is not unique to public equities. In the private equity sector, valuations are similarly dependent on complex financial modeling and negotiated assumptions. When firms like KKR realize massive windfalls—such as the recent $17 billion sale of USI to Aon—those returns are the result of years of private valuation adjustments that eventually meet a willing buyer.[2]

In the public markets, however, targets are subject to daily repricing and relentless comparison against broader benchmarks like the S&P 500. When an analyst publishes a target that is 500% above the current trading price, they are making a bold claim that the broader market has fundamentally mispriced the asset.[1][4]

Given the mathematical rigor implied by these models, retail investors might assume that price targets are highly accurate. The academic track record suggests otherwise. Multiple comprehensive studies of sell-side research have demonstrated that 12-month price targets are notoriously unreliable as actual forecasts.[6]

Research examining hundreds of thousands of price targets issued by major investment banks reveals that stocks reach or exceed their 12-month targets less than 50% of the time. Even when evaluating directional accuracy—whether the stock simply moved in the direction the analyst predicted—the success rate hovers around 54%, a figure barely better than a coin flip.[6]

Furthermore, academic literature documents a systematic upward bias in sell-side research. Analysts are far more likely to issue "Buy" ratings and optimistic price targets than they are to issue "Sell" ratings or downside targets. This persistent optimism results in an average absolute pricing error that frequently exceeds 20%, meaning the targets are not just occasionally wrong, but consistently and significantly overshot.[6]

If the models are highly sensitive and the track record is poor, why do investment banks continue to issue such aggressive price targets? The answer lies in the structural incentives of the financial industry. Sell-side analysts do not operate in a vacuum; they work for institutions that generate massive revenue from corporate relationships.[6]

The SpaceX IPO provides a clear example of these financial dynamics. Twenty-two Wall Street banks collected a combined $500 million in fees for underwriting, marketing, and allocating shares during the company's public debut. Just weeks after the regulatory quiet period expired, many of those same banks initiated coverage with enthusiastic "Buy" ratings and multitrillion-dollar valuation targets.[1]

While regulatory firewalls exist between a bank's research department and its investment banking division, the broader institutional incentives remain. Analysts who issue favorable research are more likely to secure "corporate access"—direct meetings with company executives. This access is highly prized by the bank's institutional clients, and analysts are often compensated based on their ability to facilitate these introductions.[6]

Issuing a "Sell" rating or a pessimistic price target can sever these relationships, cutting off corporate access and potentially jeopardizing future underwriting business for the bank. As a result, the path of least resistance for a sell-side analyst is almost always to maintain a bullish outlook, particularly for high-profile companies that generate significant banking fees.[6]

For retail investors, understanding this ecosystem is critical. Financial experts advise treating Wall Street price targets not as probabilistic forecasts, but as institutional position statements. A $12 trillion valuation target tells the market what a specific bank is willing to put its name behind, and it reflects the broader sentiment surrounding the stock.[1][6]

When a target sits hundreds of percentage points above the current trading price, it is a signal of extreme institutional optimism, often driven by assumptions about technological breakthroughs that are years or decades away. It is not a guarantee that the stock will reach that price within the stated 12-month timeframe.[1][6]

Ultimately, price targets are just one data point in a much larger mosaic of financial analysis. Investors who rely solely on these figures risk outsourcing their critical thinking to models that are inherently fragile and institutions that are structurally incentivized to see the glass as half full.[6]